Net profit of Hester Biosciences rose 100.49% to Rs 8.20 crore in the quarter ended September 2024 as against Rs 4.09 crore during the previous quarter ended September 2023. Sales rose 18.78% to Rs 83.69 crore in the quarter ended September 2024 as against Rs 70.46 crore during the previous quarter ended September 2023.
| Particulars | Quarter Ended |
| Sep. 2024 | Sep. 2023 | % Var. |
| Sales | 83.69 | 70.46 | 19 |
| OPM % | 22.89 | 18.75 | - |
| PBDT | 16.07 | 11.05 | 45 |
| PBT | 11.87 | 6.76 | 76 |
| NP | 8.20 | 4.09 | 100 |